Navigation Links
Cardiome Pharma Corp. Announces Final Results of Tender Offer
Date:10/16/2009

    NASDAQ: CRME    TSX: COM

VANCOUVER, Oct. 16 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ("Cardiome" or the "Company") announced the final results of its modified "Dutch Auction" tender offer to purchase for cancellation up to US$27.5 million of its common shares (the "Offer"), which expired at 5:00 p.m. (Eastern time) on October 13, 2009. Cardiome has accepted 6,470,588 of its common shares for purchase and cancellation at a purchase price of US$4.25 per share (the "Purchase Price"), for an aggregate purchase price of US$27.5 million. The purchased shares represent approximately 9.7% of the outstanding common shares of the Company as of October 13, 2009. Following the cancellation of the common shares purchased under the Offer, 60,163,885 common shares of the Company will remain issued and outstanding.

Based on the final report of the Depository, 7,209,211 common shares were properly tendered to the Offer at or below the Purchase Price. Subject to certain limited exceptions described in the offer to purchase and issuer bid circular for the Offer filed with securities regulatory authorities in Canada and the United States on September 1, 2009, shareholders who tendered their common shares to the Offer at a price equal to or less than the Purchase Price will have approximately 90% of their deposited common shares purchased by the Company. Payment for all common shares accepted for purchase under the Offer will be carried out promptly by the Depository. Because the paid up capital per common share exceeds the Purchase Price, shareholders will not be deemed to receive a dividend upon payment for their common shares.

Common shares tendered to the Offer but not purchased, i
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer
2. Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
3. Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares
4. Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth
5. Cardiome to Hold Conference Call
6. Cardiome Announces Management Transition
7. Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.
8. Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective
9. Cardiome Reports First Quarter Results
10. Cardiome to Hold Conference Call
11. CardioCareLive.com, First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... (PRWEB) June 02, 2015 Date: Thursday, ... Philadelphia City Council Chamber, 494 N. Broad Street, 4th ... the Hepatitis B Foundation will visit Philadelphia ... testing for hepatitis B and hepatitis C in Philadelphia’s ... education campaign they have created, Hep B United Philadelphia ...
(Date:6/2/2015)... Mt. View, CA (PRWEB) June 02, 2015 ... state mandated vaccination schedule for children to attend public ... Health, Judiciary and Education but bypassed the Appropriations Committee ... Senate floor 25-10 despite contentious hearings. , “We ... with Personal Belief Exemptions (PBEs) more than it will ...
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into its VIP Woman ... prestigious distinction for leadership in business. NAPW is the ... more than 700,000 members and over 200 operating Local ... this prestigious award,” said NAPW President Star Jones. “Her ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Everette-Gaines as a 2015-2016 inductee into its VIP ... with this prestigious distinction for leadership in business. ... for professional women, boasting more than 700,000 members ... pleased to welcome Kathy into this exceptional group ...
(Date:6/1/2015)... Down announces that the Golden State Warriors defeated the Houston ... face the Cleveland Cavaliers in the 2015 NBA Finals ... Oakland and the Quicken Loans Arena in Cleveland. ... State Warriors were the elite team that fans wanted to ... failures from the year and riding the knowledge of first ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2Health News:A Voice For Choice Releases A Statement As SB277 Is Referred To Single Assembly Committee And Bypasses Education and Judicial Scrutiny 2Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 3
... One-third of homeless people in the United States are obese, about ... It might seem that hunger and lack of food would ... the researchers at Harvard Medical School in Boston and the University ... of obesity among homeless people may be due to their reliance ...
... neuroscientist John Wemmie, M.D., Ph.D., is interested in the effect ... acidity or low pH, in the brain is linked to ... that changes in acidity are important for normal brain activity ... might be changing in the functional brain because we,ve been ...
... LANSING, Mich. Since Sept. 11, it has become ... non-Muslims or "infidels" to hell, but this ... a Michigan State University professor who recently published a ... time, some Western writers believe condemnation and dehumanization of ...
... May 18 (HealthDay News) -- A new test that ... was developed by analyzing the joints of dogs with ... affects more than 27 million adults in the United ... and swelling in the joints, would allow better treatment ...
... FRIDAY, May 18 (HealthDay News) -- Young people can easily ... a wide range of advertising and marketing efforts from the ... from the Center on Alcohol Marketing and Youth at the ... of alcohol messages, which may contribute to the 4,700 alcohol-related ...
... The surgical team at the Montreal Heart Institute (MHI) achieved ... sutureless aortic valve replacement through a thoracic incision just five ... this innovative procedure, which was performed by cardiac surgeons Denis ... after their operations. A novel combination ...
Cached Medicine News:Health News:One-Third of U.S. Homeless Population Is Obese: Study 2Health News:Acid in the brain 2Health News:Acid in the brain 3Health News:What does Islam say about the fate of others? 2Health News:Research With Dogs Points to Early Test for Arthritis 2Health News:Underage Drinkers Can Easily Order Alcohol From the Internet 2Health News:A North American first at the Montreal Heart Institute 2
(Date:6/1/2015)... JOLLA, Calif. , June 1, 2015 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and ... that Kleanthis G. Xanthopoulos , Ph.D. has ... as a member of Regulus, Board of Directors, ... biotechnology industry.  Paul Grint, M.D., who previously served ...
(Date:6/1/2015)... N.C. , June 1, 2015  bioMérieux, a ... diagnostics, has been invited to join the White ... antibiotic use in the U.S. as a means to ... sectors, will gather tomorrow, June 2, 2015, to discuss ... five years to slow the emergence of antibiotic-resistant bacteria, ...
(Date:6/1/2015)... -- Select Medical Holdings Corporation (NYSE: SEM ) ... that Select Medical Corporation ("Select") formed with Welsh, Carson, ... acquisition of Concentra Inc.  Cressey & Company has also ... About Select Medical Corporation Select is ... clinics in the United States . ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3
... Research Foundation,s ADAPT-DES Study to Quantify Causes and Cures of Drug ... ... Corporation,(Nasdaq: VOLC ) [TCT Booth #2013 Level 2], a leading ... sponsorship of the first major study designed to,examine the role of ...
... results of the,first- ever randomized study to ... stent, with Boston Scientific,s Taxus drug-eluting,stent in ... efficacy at,30-day and six- month follow-up, reported ... director of the catheterization laboratory at,the Academic ...
Cached Medicine Technology:Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 2Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 3Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 4Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) and Boston Scientific's Taxus(R) Stent in Patients at High Risk of Restenosis 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: